28 April 2023
Our Culture
...
13 April 2023
Our History
...
13 April 2023
Partnering
...
13 April 2023
Patients
...
13 April 2023
Pipeline
As a global biopharmaceutical company with a focus on innovation and specialty care, Ipsen is building a strong and sustainable portfolio of medicines to meet patients’ and their healthcare teams’ needs. We prioritize best-in-class and first-in-class t...
18 April 2023
13 April 2023
Responsibility
...
-
14 November 2023
-
14 November 2023
Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
PARIS, FRANCE, 13 November, 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT) today announced full results from the pivotal Phase III ELATIVE® trial, which are being presented in a late-breaking oral session (Abstract #484,...
-
10 May 2024
- 3 mins read
-
10 May 2024
- 3 mins read
Seven Years Out: The road to recovery from a stroke-like episode
Randy loves to read, enjoy the outdoors, and spend time with his family. He enjoys going to the gym and took up aquatic therapy to exercise and make new friends. He’s come a long way since he experienced a car accident, which led to traumatic brain injur...
-
02 May 2023
-
02 May 2023